India · Delayed Price · Currency is INR Poly Medicure Statistics
Total Valuation
Poly Medicure has a market cap or net worth of INR 174.11 billion. The enterprise value is 169.81 billion.
| Market Cap | 174.11B |
| Enterprise Value | 169.81B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Aug 28, 2026 |
Share Statistics
Poly Medicure has 101.36 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Current Share Class | 101.36M |
| Shares Outstanding | 101.36M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 36.98% |
| Owned by Institutions (%) | 20.39% |
| Float | 36.34M |
Valuation Ratios
The trailing PE ratio is 55.31 and the forward PE ratio is 39.70. Poly Medicure's PEG ratio is 2.21.
| PE Ratio | 55.31 |
| Forward PE | 39.70 |
| PS Ratio | 8.72 |
| PB Ratio | 5.53 |
| P/TBV Ratio | 6.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 70.67 |
| PEG Ratio | 2.21 |
Enterprise Valuation
| EV / Earnings | 53.89 |
| EV / Sales | 8.50 |
| EV / EBITDA | 36.68 |
| EV / EBIT | 50.14 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | -5.70 |
| Interest Coverage | 15.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.23% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.30% |
| Revenue Per Employee | 7.64M |
| Profits Per Employee | 1.21M |
| Employee Count | 3,082 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Poly Medicure has paid 1.09 billion in taxes.
| Income Tax | 1.09B |
| Effective Tax Rate | 25.82% |
Stock Price Statistics
The stock price has decreased by -12.65% in the last 52 weeks. The beta is 0.01, so Poly Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -12.65% |
| 50-Day Moving Average | 1,683.72 |
| 200-Day Moving Average | 1,602.31 |
| Relative Strength Index (RSI) | 48.76 |
| Average Volume (20 Days) | 14,577 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Poly Medicure had revenue of INR 19.97 billion and earned 3.15 billion in profits. Earnings per share was 31.06.
| Revenue | 19.97B |
| Gross Profit | 13.88B |
| Operating Income | 3.33B |
| Pretax Income | 4.22B |
| Net Income | 3.15B |
| EBITDA | 4.57B |
| EBIT | 3.33B |
| Earnings Per Share (EPS) | 31.06 |
Balance Sheet
The company has 8.27 billion in cash and 3.54 billion in debt, with a net cash position of 4.73 billion or 46.71 per share.
| Cash & Cash Equivalents | 8.27B |
| Total Debt | 3.54B |
| Net Cash | 4.73B |
| Net Cash Per Share | 46.71 |
| Equity (Book Value) | 31.49B |
| Book Value Per Share | 306.44 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 2.46 billion and capital expenditures -3.08 billion, giving a free cash flow of -620.17 million.
| Operating Cash Flow | 2.46B |
| Capital Expenditures | -3.08B |
| Depreciation & Amortization | 1.24B |
| Net Borrowing | 712.38M |
| Free Cash Flow | -620.17M |
| FCF Per Share | -6.12 |
Margins
Gross margin is 69.49%, with operating and profit margins of 16.66% and 15.77%.
| Gross Margin | 69.49% |
| Operating Margin | 16.66% |
| Pretax Margin | 21.12% |
| Profit Margin | 15.77% |
| EBITDA Margin | 22.88% |
| EBIT Margin | 16.66% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.82% |
| Shareholder Yield | -0.61% |
| Earnings Yield | 1.81% |
| FCF Yield | -0.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Poly Medicure is 1,824.83, which is 6.23% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,824.83 |
| Price Target Difference | 6.23% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 19.50% |
| EPS Growth Forecast (3Y) | 23.90% |
Stock Splits
The last stock split was on March 24, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |